紧密连接
发病机制
胱硫醚β合酶
势垒函数
医学
肿瘤坏死因子α
碳酸钙-2
炎症
溃疡性结肠炎
肠粘膜
生物
免疫学
病理
内科学
细胞生物学
酶
细胞
生物化学
疾病
半胱氨酸
作者
Shanwen Chen,Shuai Zuo,Jing Zhu,Taohua Yue,Dingfang Bu,Xin Wang,Pengyuan Wang,Yisheng Pan,Yucun Liu
标识
DOI:10.1093/ecco-jcc/jjz027
摘要
BACKGROUND AND AIMS: Endogenous H2S regulates multiple physiological and pathological processes in colon epithelial tissues. The current study investigated the role of cystathionine β-synthase [CBS], a major producer of H2S in colon epithelial cells, in the pathogenesis of ulcerative colitis [UC]-related intestinal barrier injury. The expression and DNA methylation level of CBS were investigated in inflamed and non-inflamed colon tissues collected from UC patients, and the effect of decreased CBS levels on Caco-2 monolayer barrier injury and altered status of tight junctions elicited by tumour necrosis factor/interferon [TNF/IFN] was determined. METHODS: The expression of CBS and the methylation level of the CBS promoter were assessed in non-inflamed and inflamed colon epithelial tissue samples collected from UC patients. Barrier function, status of tight junction proteins and activation of the NF-κB p65-mediated MLCK-P-MLC signalling pathway were further investigated in Caco-2 monolayers. RESULTS: Decreased expression of CBS and elevated methylation levels of the CBS promoter were observed in inflamed sites compared with in non-inflamed sites in the colon epithelial samples from UC patients. In Caco-2 monolayers, decreased expression of CBS exacerbated TNF/IFN-induced barrier injury and altered localization of tight junction proteins. Decreased expression of CBS predisposed Caco-2 monolayers to injury elicited by TNF/IFN via augmentation of the NF-κB p65-mediated MLCK-P-MLC signalling pathway. CONCLUSIONS: Decreased expression of CBS propagates the pathogenesis of UC by exacerbating inflammation-induced intestinal barrier injury. Elevated methylation of the CBS promoter might be one of the mechanisms underlying the decreased expression of CBS in inflamed sites of colon epithelial tissues from UC patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI